May
Rare Diseases and the Changing NHS
Expert insight on how NHS reform, funding pressures and system shifts are shaping Rare Disease care in 2026
Join our expert panel for a review of how Rare Disease services are evolving across the NHS. Discover how policy change, commissioning dynamics and emerging system priorities are affecting access, pathways and opportunities for collaboration in 2026.
June
Diabetes and the Changing NHS
Changing Pathways: What Life Sciences need to know about Diabetes care in today’s NHS
Shailen Rao explores the latest NHS strategies for Diabetes care, including prevention, technology adoption and integrated service delivery and what they mean for Life Sciences companies seeking to support pathway reform and improved outcomes.
Rare Disease: No HTA Approval? – No Problem!
From national roadblock to local breakthrough: practical pathways to Rare Disease funding
What happens when HTA approval isn’t achievable? Join market access expert Phil Cox to explore how Rare Disease teams can pivot from national roadblocks to targeted, high-impact NHS funding strategies for the most severely affected patients – even without formal approval.